Quality of Treatment Selection for Medicare Beneficiaries With Cancer
LIS participants were less likely to receive systemic therapy at all and were more likely to receive treatments that receive low NCCN EB scores.
Authors
- Peter B. Bach (ORCID: https://orcid.org/0000-0001-5175-402X)
- Aaron Philip Mitchell (ORCID: https://orcid.org/0000-0003-3639-3515)
- Nirjhar Chakraborty (ORCID: https://orcid.org/0009-0003-8104-4311)
- Pranam Dey
- Lindsey E. Roeker (ORCID: https://orcid.org/0000-0002-3806-059X)
- Mithat Gönen (ORCID: https://orcid.org/0000-0001-8683-8477)
- Akriti Mishra Meza (ORCID: https://orcid.org/0000-0002-3477-5037)
- Sara Tabatabai (ORCID: https://orcid.org/0000-0002-5498-7176)
- Sonia Persaud (ORCID: https://orcid.org/0009-0008-5666-7994)
- Sham Mailankody (ORCID: https://orcid.org/0000-0002-2815-9561)
- Prabal K. De (ORCID: https://orcid.org/0000-0002-0043-3207)
- Angela Green (ORCID: https://orcid.org/0000-0003-2047-0352)
- Andrew S. Epstein (ORCID: https://orcid.org/0000-0003-1808-3070)
- Niti U. Trivedi (ORCID: https://orcid.org/0000-0002-3967-6492)
- Victoria Blinder (ORCID: https://orcid.org/0000-0002-1448-8671)
- Hannah E. Fuchs (ORCID: https://orcid.org/0000-0003-2426-0096)
- Bobby Daly
Institutions
- City College of New York (US)
- Memorial Sloan Kettering Cancer Center (US)
- Yale University (US)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1200/jco.24.00459
- Citations
- 7
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 7.90